Deisseroth A - Search Results

1

Deisseroth A, Guo D, Wang T, Fujii T, Fu SQ, Cote R, Savinov S, Liu F, Loewe R, Pizzorno G, Austin D, Crystal R, Chung I. Deisseroth A, et al. Cancer J Sci Am. 1998 May;4 Suppl 1:S5-7. Cancer J Sci Am. 1998. PMID: 9619264 No abstract available.

2

The use of chemotherapy resistance in cancer treatment.

Deisseroth AB, Pizzorno G. Deisseroth AB, et al. Cancer J Sci Am. 1997 Mar-Apr;3(2):60-9. Cancer J Sci Am. 1997. PMID: 9099453 Review. No abstract available.

3

Results of retroviral and adenoviral approaches to cancer gene therapy.

Yin LH, Fu SQ, Nanakorn T, Garcia-Sanchez F, Chung I, Cote R, Pizzorno G, Hanania E, Heimfeld S, Crystal R, Deisseroth A. Yin LH, et al. Among authors: deisseroth a. Stem Cells. 1998;16 Suppl 1:247-50. doi: 10.1002/stem.5530160830. Stem Cells. 1998. PMID: 11012168 Review.

4

Combinatorial chemistry in cancer drug development.

Leonard KA, Deisseroth AB, Austin DJ. Leonard KA, et al. Among authors: deisseroth ab. Cancer J. 2001 Jan-Feb;7(1):79-83. Cancer J. 2001. PMID: 11269651 Review.

5

Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectors.

Fu S, Deisseroth AB. Fu S, et al. Among authors: deisseroth ab. Hum Gene Ther. 1997 Jul 20;8(11):1321-30. doi: 10.1089/hum.1997.8.11-1321. Hum Gene Ther. 1997. PMID: 9295127

6

Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.

Garcia-Sanchez F, Pizzorno G, Fu SQ, Nanakorn T, Krause DS, Liang J, Adams E, Leffert JJ, Yin LH, Cooperberg MR, Hanania E, Wang WL, Won JH, Peng XY, Cote R, Brown R, Burtness B, Giles R, Crystal R, Deisseroth AB. Garcia-Sanchez F, et al. Among authors: deisseroth ab. Blood. 1998 Jul 15;92(2):672-82. Blood. 1998. PMID: 9657770 Free article.

7

Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.

Chung I, Schwartz PE, Crystal RG, Pizzorno G, Leavitt J, Deisseroth AB. Chung I, et al. Among authors: deisseroth ab. Cancer Gene Ther. 1999 Mar-Apr;6(2):99-106. doi: 10.1038/sj.cgt.7700017. Cancer Gene Ther. 1999. PMID: 10195877

8

Multidrug Resistance and Prodrug Activation for Cancer Gene Therapy of Breast Cancer.

Fujii T, Fu SQ, Yin LH, Nanakorn T, Sanchez FG, Cooperberg M, Guo D, Wang T, D L, Pizzorno G, Deisseroth A. Fujii T, et al. Among authors: deisseroth a. Breast Cancer. 1997 Dec 25;4(4):210-212. doi: 10.1007/BF02966508. Breast Cancer. 1997. PMID: 11091601

9

The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.

Peng XY, Won JH, Rutherford T, Fujii T, Zelterman D, Pizzorno G, Sapi E, Leavitt J, Kacinski B, Crystal R, Schwartz P, Deisseroth A. Peng XY, et al. Among authors: deisseroth a. Cancer Res. 2001 Jun 1;61(11):4405-13. Cancer Res. 2001. PMID: 11389068

10

Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.

Fujii T, Austin D, Guo D, Srimatkandada S, Wang T, Kubushiro K, Masumoto N, Tsukazaki K, Nozawa S, Deisseroth AB. Fujii T, et al. Clin Cancer Res. 2003 Nov 1;9(14):5423-8. Clin Cancer Res. 2003. PMID: 14614029

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters